ODDB.org: Open Drug Database

Swissmedic Registration	66132	Date of registration	29.03.2017
Company name	Boehringer Ingelheim (Schweiz) GmbH	Revision date
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	07.06.20.	Revocation Date
Index Therapeuticus (Swissmedic)	07.06.20.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Glyxambi 10 mg / 5 mg	Filmtabletten	Coated tablets (Empagliflozinum 10 mg, Linagliptinum 5 mg)	A10BD19	CI

2025	©ywesee GmbH